Prostate Cancer Screening

Prostate cancer screening aims to find prostate cancer before it causes symptoms. The main test is the PSA (prostate-specific antigen) blood test, sometimes combined with a digital rectal examination (DRE). Whether every older man should be screened is a genuinely debated question — the right answer depends on individual risk and preferences.

Benefits and limitations

• Benefit — can find aggressive prostate cancer early, when cure is most likely.
• Limitation — also finds slow-growing cancers that may never have caused harm ("over-diagnosis") leading to possible over-treatment (surgery or radiation with their side-effects).
• PSA can be raised by things other than cancer — BPH, urinary infection, recent ejaculation, cycling, recent prostate examination.
• A single high PSA doesn't mean cancer — it means more evaluation.

A practical Indian guide

• Discuss PSA screening with a Health Expert from age 50 — or 45 if a close relative had prostate cancer, or BRCA mutation in the family.
• A single baseline PSA between 45-50 helps define future risk.
• Stop screening around 70-75 or when life expectancy is under 10 years — screening rarely helps at that point.
• If PSA is elevated — repeat PSA, consider multiparametric MRI of the prostate, and targeted biopsy only if needed.
• Active surveillance is an appropriate and increasingly used approach for many low-risk cancers — not every cancer needs immediate treatment.

Between screening and no screening

Informed decision-making is the standard: no one should be screened without understanding what it means, and no one should be denied screening who understands and wants it. A Health Expert can help weigh your personal risks (family history, BRCA status, ethnicity, symptoms) and preferences.